Patents by Inventor Karolyn Marie Troupe

Karolyn Marie Troupe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Recombinant NDV antigen and uses thereof
    Patent number: 10633667
    Abstract: The present invention encompasses NDV vaccines. The vaccine may be a subunit vaccine based on HN of NDV. The NDV HN may be expressed in plants or algae including microalgae. The invention also encompasses recombinant vectors encoding and expressing NDV antigens, epitopes or immunogens which can be used to protect animals against NDV. It encompasses also a vaccination regime compatible with the DIVA strategy, including a prime-boost scheme using viral vector or inactivated vaccines and subunit vaccines.
    Type: Grant
    Filed: December 28, 2010
    Date of Patent: April 28, 2020
    Assignee: BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
    Inventors: Xuan Guo, Karolyn Marie Troupe, Bradley J. Feilmeier, Joyce A. Pritchard, Julio Sergio Cruz-Coy
  • FOOT AND MOUTH DISEASE VIRUS RECOMBINANT VACCINES AND USES THEREOF
    Publication number: 20110236416
    Abstract: The present invention encompasses FMDV vaccines or compositions. The vaccine or composition may be a vaccine or composition containing FMDV antigens. The invention also encompasses recombinant vectors encoding and expressing FMDV antigens, epitopes or immunogens which can be used to protect animals, in particular ovines, bovines, caprines, or porcines, against FMDV.
    Type: Application
    Filed: March 11, 2011
    Publication date: September 29, 2011
    Inventors: Jean-Christophe Audonnet, Xuan Guo, Bradley J. Feilmeir, Karolyn Marie Troupe, Michel Bublot, Kevin Cox
  • RECOMBINANT NDV ANTIGEN AND USES THEREOF
    Publication number: 20110162115
    Abstract: The present invention encompasses NDV vaccines. The vaccine may be a subunit vaccine based on HN of NDV. The NDV HN may be expressed in plants or algae including microalgae. The invention also encompasses recombinant vectors encoding and expressing NDV antigens, epitopes or immunogens which can be used to protect animals against NDV. It encompasses also a vaccination regime compatible with the DIVA strategy, including a prime-boost scheme using viral vector or inactivated vaccines and subunit vaccines.
    Type: Application
    Filed: December 28, 2010
    Publication date: June 30, 2011
    Inventors: Xuan Guo, Karolyn Marie Troupe, Bradley J. Feilmeier, Joyee A. Pritchard, Julio Sergio Cruz-Coy